Market Intelligence

How Xcel Brands XELB sensitive is to interest rates Q4 2025 EPS Beats Forecasts GYRE Gyre Therapeutics Inc notches 102 percent year over year revenue growth shares climb despite modest EPS miss QVC Group QVCGP Stock Start a Position Eye on Rally 20260415 NWPX Infrastructure NWPX Q2 earnings lift shares 278 as revenue climbs 68 yearoveryear Nvidia Earnings and CEO Jensen Huangs Commentary on China Export Controls Expected to Test US Equities Ralliant Corporation RAL Q1 2026 Earnings Beat Revenue NA EPS 057 Amber Enterprises Shares Slide 18 on Q4 Results JV Losses and Margin Pressure Raise Concerns Irans Economy in Freefall Charts Reveal Deepening Crisis Amid Hardline Stance Aon AON Delivers Q1 2026 Beat EPS 648 vs 646 Expected Jim Cramer Highlights FedExs Operational Strength Amid Logistics Sector Transformation RLX RLX Stock Up 116 Key Resistance at 230 20260518 DarioHealth DRIO Stock Slides 180 Support at 779 20260519 Liberty LBRDK Q3 2025 Earnings Outperformance Signals Momentum Intuitive Surgical ISRG Delivers Q1 2026 Beat EPS 250 vs 214 Expected Greeces Q1 2026 Budget Surplus of 52bn More Than Doubles Official Target TCPC Q1 2026 Earnings EPS Surpasses Estimates Despite Share Price Decline Truth or Consequences Brewery Tour Featuring MillionBat Migration Draws Tourism Interest Estate Planning Strategies for HighIncome Trusts Shifting Tax Burden to Beneficiaries President Trump Delays AI Executive Order Citing Concerns Over Potential Obstacles to Innovation Corporate America Q2 Earnings Surpass Wall Street Slowdown Fears Amazon Faces Allegations of Profiting from NowIllegal Policy Technologys Role in Advancing Healthcare Innovation WHLR Q2 2024 Earnings EPS of 365 Strengthens as Stock Declines 136 NOV Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Conditions Pasithea Therapeutics KTTA Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Reaction ADAMH Q1 2026 Earnings Earnings Surge Past Estimates with 75 Surprise Lindsay Corporation LNN Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds TScan Therapeutics TCRX Rallies 39 as Shares Test Key Resistance Levels Heron Therapeutics HRTX Slides to 086 as Selling Pressure Persists Western Midstream Partners WES Rises 161 as Energy Infrastructure Demand Supports Uptrend Petco WOOF Hovers Near Support Amid Modest Decline